Our news

  • Cochrane UK will continue to host virtual Review Author training workshops. These workshops are fully funded by Cochrane UK and are free to Cochrane Authors. Cochrane UK and the faculty team continue to revise the format of the workshops to promote interaction with the facilitators and incorporate different learning formats.The dates of the...
    August 3 2020
  • Measurement of β‐D‐glucans to detect invasive fungal infection in immunocompromised peopleWhy is improving the diagnosis of invasive fungal infections important?Fungal infections occur in people who are unable to fight infection, and these infections can be life‐threatening in this group of people. Fungal infections are difficult to diagnose....
    July 23 2020
  • Cochrane Community BlogEve Tomlinson, NIHR Network Support Fellow for the Cochrane Cancer Network presents the work completed across the cancer network to complete an exercise in stakeholder mapping.The Cochrane Cancer Network supports the work of six Cochrane Review Groups (CRGs): Breast Cancer, Childhood Cancer, Gynaecological, Neuro-oncology...
    June 24 2020
  • Telephone interventions for managing symptoms in adults with cancer. This is particularly important at the moment for people with cancer, who have been advised to stay at home due to COVID-19.People with cancer experience a variety of symptoms such as depression, anxiety, fatigue and pain caused by their disease and its treatment. These are often...
    June 3 2020
  • COVID-19 (coronavirus disease) - Cochrane Gynaecological, Neuro-oncology and Orphan CancersCoronavirus disease (COVID-19) is caused by a new strain of Coronavirus (SARS-CoV-2) discovered in 2019, and not previously identified in humans. Common symptoms include fever, cough, and shortness of breath. On March 11 2020, the World Health Organization (...
    April 14 2020
  • The aim of the register is to support rapid evidence synthesis by all systematic review producers, including Cochrane's work on Rapid Reviews in response to COVID-19. The register helps systematic reviewers prioritize topics, identify available evidence, and produce urgently needed reviews for front-line health professionals, public health...
    April 8 2020
  • COVID-19 pandemic: statement for CGNOC collaborators and colleaguesWe recognise that these are uncertain times and the impact of the COVID-19 pandemic will be felt by many of our collaborators and colleagues. We want to reassure all of you that your health, and your current priorities at work and home, are of the utmost importance to us.For those...
    March 30 2020
  • Green tea consumption and risk of developing cancer: can we make sense of it?Authors' conclusionsOverall, findings from experimental and nonexperimental epidemiological studies yielded inconsistent results, thus providing limited evidence for the beneficial effect of green tea consumption on the overall risk of cancer or on specific cancer sites....
    March 9 2020
  • Oral etoposide for treatment and/or maintenance treatment of recurrent epithelial ovarian cancer.Why it is important to do this review:Oral etoposide is a potential candidate for treatment and/or maintenance therapy of recurrent EOC, as it does not exhibit cross-resistance to platinum or paclitaxel which are used as the first-line chemotherapeutic...
    February 21 2020
  • Interventions to improve insulin resistance for the prevention of endometrial cancerBackgroundDescription of the conditionCancer of the womb (uterus) is the most common cancer affecting the female reproductive system in the developed world. Most womb cancers arise from abnormal growth of the womb lining (endometrium) and are termed endometrial...
    January 30 2020

Pages

Subscribe to Our news